XENE FY 2018 Earnings — Xenon Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

XENEXenon Pharmaceuticals Inc.

$5B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$6M

Operating Income

-$38M

Net Income

-$34M

EPS (Diluted)

$-1.78

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$122M

Total Liabilities

$19M

Stockholders' Equity

$103M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$311,000	-100.0%
Gross Profit	-$6M	-$25M	+76.2%
Operating Income	-$38M	-$33M	-16.7%
Net Income	-$34M	-$31M	-12.4%